These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28638844)

  • 1. Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network.
    Schmidt M; Hearn B; Gabriel M; Spencer MD; McCurdy L
    Open Forum Infect Dis; 2017; 4(2):ofx086. PubMed ID: 28638844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).
    Drew R; Brenneman E; Funaro J; Lee HJ; Yarrington M; Dicks K; Gallagher D
    PLOS Digit Health; 2023 Aug; 2(8):e0000323. PubMed ID: 37531342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Kritsotakis EI; Johnston P; Kenny T; Ntziora F; Cartwright K
    Clin Microbiol Infect; 2019 Jul; 25(7):905.e1-905.e7. PubMed ID: 30502491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.
    Bradley AC; Wingler MJB; Artman KL; Ward LM; Lucar J
    Ther Adv Infect Dis; 2023; 10():20499361231195966. PubMed ID: 37667754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Morgan R; Chelaghma N; Palit J; Keil C; Omer R; Cartwright K; Kritsotakis EI
    J Antimicrob Chemother; 2021 Jul; 76(8):2204-2212. PubMed ID: 33895844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.
    Brenneman E; Funaro J; Dicks K; Yarrington M; Lee HJ; Erkanli A; Hung F; Drew R
    JAC Antimicrob Resist; 2023 Feb; 5(1):dlad019. PubMed ID: 36824226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.
    Yang A; Fung R; Brunton J; Dresser L
    Can J Infect Dis Med Microbiol; 2013; 24(2):74-8. PubMed ID: 24421805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of outcome in patients with infective endocarditis receiving outpatient parenteral antibiotic therapy (OPAT).
    Durojaiye OC; Morgan R; Chelaghma N; Kritsotakis EI
    J Infect; 2021 Dec; 83(6):644-649. PubMed ID: 34614400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal use via outpatient parenteral antimicrobial therapy.
    Chew SM; Heath CH; Petursson C; Boan PA; Robinson JO; Italiano CM; Dyer JR; Manning L; Ingram PR
    Mycoses; 2022 Oct; 65(10):946-952. PubMed ID: 35923125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.
    Yan M; Elligsen M; Simor AE; Daneman N
    Can J Infect Dis Med Microbiol; 2016; 2016():8435257. PubMed ID: 27366183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
    Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
    J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Outpatient Parenteral Antimicrobial Therapy in Children.
    Fernandes P; Milliren C; Mahoney-West HM; Schwartz L; Lachenauer CS; Nakamura MM
    Pediatr Infect Dis J; 2018 Feb; 37(2):157-163. PubMed ID: 28763427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy.
    Certain LK; Benefield RJ; Newman M; Zhang M; Thomas FO
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac199. PubMed ID: 35794930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
    Shah A; Petrak R; Fliegelman R; Shrestha N; Allison G; Zurlo J; Parker S; Poretz D; McKinsey D; Dougherty M; Martinelli L; Mathur A; Rodriguez A; Smith MW
    Clin Infect Dis; 2019 Mar; 68(7):1160-1165. PubMed ID: 30247512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Palms DL; Jacob JT
    Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.
    Hassanzai M; Adanç F; Koch BCP; Verkaik NJ; van Oldenrijk J; de Bruin JL; de Winter BCM; van Onzenoort HAW
    Ther Adv Infect Dis; 2023; 10():20499361231214901. PubMed ID: 38127471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does comorbidity index predict OPAT readmission?
    Stubbs RD; Shorten RJ; Benedetto V; Muir A
    JAC Antimicrob Resist; 2023 Dec; 5(6):dlad125. PubMed ID: 38021037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
    Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
    N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Huang V; Ruhe JJ; Lerner P; Fedorenko M
    BMC Pharmacol Toxicol; 2018 Aug; 19(1):50. PubMed ID: 30081959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.